Silver-coated endotracheal tube dramatically reduces resistant infections

May 19, 2008

A silver-coated endotracheal tube may reduce infections with highly resistant bacteria over traditional tubes by nearly half, according to the results of a large randomized trial to be presented at the American Thoracic Society’s 2008 International Conference in Toronto on Monday, May 19.

Patients who are on ventilators are often at risk for developing ventilator-associated pneumonia (VAP) because of resistant bacteria.

“VAP is a serious disease with significant mortality,” said lead investigator, Andrew Shorr, M.D., M.P.H., of Washington Hospital Center in Washington, D.C. “Crude mortality rates from VAP approach 25 to 30 percent and VAP rates are now thought to reflect hospital quality. These infections include highly resistant pathogens, such as methicillin-resistant Staphylococcus aureus or MRSA, which are the most troubling ones and often the hardest to treat. The average costs associated with treatment of VAP exceed $40,000 because of the impact on length of stay in the ICU.”

To test the efficacy of the silver-coated tube in preventing infections, the study included a modified intention-to-treat population of 1,509 subjects, balanced between traditional endotracheal tubes and the silver coated ones. The researchers used brochoavelolar lavage fluid cultures to ascertain the presence of pathogenic organisms and classified as “highly resistant” organisms MRSA, Pseudomonas aeruginosa (PA) and Acinetobacter bumanii (AB).

They found that VAP in all its forms was reduced by nearly 40 percent in the population with the silver-coated endotracheal tubes and that highly resistant infections were less than half as likely to occur in those with the silver-coated tubes.

“What we show in this present analysis is that the silver-coated breathing tube prevents infections due to the most highly resistant pathogens. Other prevention strategies for VAP have not always been shown to impact the rates of infection with these highly resistant strains,” said Dr. Shorr. “Given the importance of MRSA, PA and AB in the ICU, utilization of the silver-coated endotracheal tube may help contain the spread of antimicrobial resistance.”

Source: American Thoracic Society

Explore further: Hormonal therapy for transsexualism safe and effective

add to favorites email to friend print save as pdf

Related Stories

Kim Dotcom slams Megaupload 'data massacre'

5 hours ago

Megaupload founder Kim Dotcom Thursday condemned a Dutch company's decision to delete million of files belonging to users of his defunct website, calling it "the largest data massacre in the history of the ...

The broken symphony of swinging metronomes

5 hours ago

An experiment with 30 metronomes reveals chimera states which combine aspects of synchrony and of disorder. Researchers had been looking for such states for ten years.

Wooden beam could be detached part of shipwreck

5 hours ago

A wooden beam that has long been the focus of the search for a 17th century shipwreck in northern Lake Michigan was not attached to a buried vessel as searchers had suspected, but still may have come from the elusive Griffin ...

US seizure of journalist records called 'chilling'

5 hours ago

The US government's secret seizure of Associated Press phone records had a "chilling effect" on newsgathering by the agency and other news organizations, AP's top executive said Wednesday.

Microsoft mulled buying Nokia unit

6 hours ago

Microsoft was in talks to boost its position in the mobile phone market by buying the devices business from Nokia but failed to seal a deal, the Wall Street Journal reported Wednesday.

Recommended for you

Hormonal therapy for transsexualism safe and effective

Jun 18, 2013

Hormonal therapy for transsexual patients is safe and effective, a multicenter European study indicates. The results will be presented Saturday at The Endocrine Society's 95th Annual Meeting in San Francisco.

Royalty Pharma lets Elan takeover bid expire

Jun 18, 2013

Royalty Pharma has let its latest takeover bid for Irish drugmaker Elan lapse as it decided against pressing ahead with a court challenge of a requirement that it withdraw the offer.

User comments : 0

More news stories

LA to give every student an iPad; $30M order

Los Angeles' school system, the second largest in the United States, is ordering iPads for all its students, handing Apple a major success in its quest to make the tablet computer a replacement for textbooks.